echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Human nose model reveals first steps of SARS-CoV-2 and RSV infection

    Human nose model reveals first steps of SARS-CoV-2 and RSV infection

    • Last Update: 2022-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Using nasal organoids that mimic the complex interactions between human cells and viruses, the team showed the relationship between infection with the SARS-CoV-2 virus that causes COVID-19 and infection with respiratory syncytial virus, a major pediatric respiratory virus.


    The model has also proven to be a useful tool for testing the effectiveness of treatments such as palivizumab, an FDA-approved monoclonal antibody, to prevent severe RSV disease in high-risk infants


    "In the case of respiratory viruses, such as SARS-CoV-2 and RSV, infection begins when people inhale the virus," said corresponding author Pedro Piedra, PhD, professor of molecular virology, microbiology, pediatrics, pharmacology and chemical biology at Baylor University.


    The epithelial cells on the inside of the nose are exposed to the air on one side and the circulatory system on the other


    "Our three-dimensional organoid system replicates this natural situation in the laboratory using nasal epithelium collected from nasal swabs," explained first author Anubama Rajan, PhD, a postdoctoral associate in Piedra's lab


    To study the interaction between SARS-CoV-2 or RSV and the nasal epithelium, the researchers simulated natural infection by placing each virus individually on the air side of a culture plate and studied the changes that occurred on nasal organoids


    "We observed distinct responses to SARS-CoV-2 and RSV infection," said co-author Vasanthi Avadhanula, PhD, assistant professor of molecular virology and microbiology at Baylor University


    The team also used a human nasal organoid model of RSV infection to test the effectiveness of palivizumab


    "In our model, palivizumab effectively prevented RSV infection in a concentration-dependent manner," Avadhanula said


    In this study, the team describes for the first time a non-invasive, reproducible and reliable method to create human nose organoids, allowing long-term studies


    Another benefit of using this novel human nose organoid system is that it can reveal how the initial control of a person's infection occurs and provide insights into how one person is more susceptible to the virus than another


    Anubama Rajan, Ashley Morgan Weaver, Gina Marie Aloisio, Joseph Jelinski, Hannah L.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.